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Despite the widespread use of disinfectants and antiseptics in hospitals, acquired resistance to current disin-
fectants has rarely been reported. Germicides, as with medications, should only be used when their benefit 
as demonstrated by scientific studies exceeds possible risks to human health or the environment.Disinfectant
Antibiotic
Chemical sterilants
Antibiotic resistanceBioinformatics Building, CB#BACKGROUND
The Centers for Disease Control and Prevention (CDC) stated, “Anti-
biotics are the foundation of modern medicine,” and noted that antibi-
otics “have transformed health care around the world—making once
deadly diseases treatable and saving millions of lives.”1 Not surpris-
ingly, then, antibiotics are frequently administered to hospitalized
patients. From 2006 to 2012, 55.1% of inpatients received at least 1
dose of antibiotics during their hospitalization, and the overall national
days of therapy was 755 per 1000 patient days.2 A prospective point
prevalence study in 2007 of 14,414 patients in 1265 intensive care units
from 75 countries reported that, on the day of study, 71% of all patients
were receiving antibiotics.3 Although antibiotics can be lifesaving, anti-
biotic use is associated with an increased risk of Clostridioides difficile
and Candida, allergic reactions, drug interactions, adverse events (eg,
renal failure), and development of antibiotic resistance.1 Importantly,
the CDC estimates that 30% to 50% of antibiotics prescribed in hospitals
are unnecessary or inappropriate.4 Further, the CDC has stated that,
“There is no doubt that overprescribing andmisprescribing are contrib-
uting to the growing challenges posed by Clostridioides difficile and anti-
biotic-resistant bacteria.”4 TheWorld Health Organization has observed
that, “Antibiotic resistance is one of the biggest threats to global health,
food security, and development today.”5 The CDC has estimated that
each year in the United States at least 2 million people get an antibi-
otic-resistant infection and at least 23,000 people die as a result.6Antiseptics (eg, alcohol, chlorhexidine, iodine compounds) are
widely used in health care for hand hygiene by health care person-
nel,7,8 skin antisepsis for invasive procedures (eg, placement of a cen-
tral venous catheter),7,8 skin antisepsis of patients and surgical staff
prior to surgery,9 daily bathing of patients residing in an intensive care
unit,8 and oral care of intubated patients.10 Low-level disinfectants (eg,
sodium hypochlorite, quaternary ammonium compounds, improved
hydrogen peroxide, quaternary ammonium compounds and alcohol)
are recommended to be used in the United States for daily and termi-
nal patient room cleaning and disinfection and for cleaning and disin-
fection of shared patient equipment.11−13 High-level disinfectants and
chemical sterilants (eg, glutaraldehyde, ortho-phthalaldehyde) are
used to perform high-level disinfection on semicritical items (eg, gas-
trointestinal endoscopes, vaginal specula, laryngoscopes) or chemical
sterilization of heat-sensitive critical items.11−13
Given the growing threat of antibiotic resistance, the issue of
whether there is cross-resistance in bacteria between antibiotics and
germicides used in health care has been repeatedly raised in recent
decades. The twofold issues are (1) whether antibiotic-resistant bac-
teria is more likely to exhibit resistance to one or more germicides
than a similar but non-antibiotic resistant strain, and (2) whether
bacteria that demonstrate increased tolerance or reduced susceptibil-
ity to germicides are more likely to exhibit antibiotic resistance. The
issues of cross-resistance between antibiotics and germicides have
been reviewed.14−25
TERMINOLOGY
The importance of using the proper terminology when discussing
the relationship between antibiotic and germicide resistance has
Table 1
Similarities and differences between antibiotic and germicide resistance
Similarities
Intrinsic resistance (eg, spores are resistant to alcohols) and extrinsic resistance
(eg, efflux pumps for heavy metals) are well described.
Acquired mechanisms of resistance are similar (eg, impermeability, efflux
pumps).
Biofilms impair inactivation/killing.
Inactivation is dependent on the concentration and duration of contact with the
antibiotic or germicide.
Differences
Most antibiotics inhibit a specific target in a biosynthetic process.
Most biocides have multiple concentration-dependent targets, with subtle
effects occurring at low concentrations and more damaging ones at higher
concentrations.been emphasized in several reviews.16−18,24 Biocidal agents (also
termed germicides), including antiseptics (germicides used on the
skin) and disinfectants (germicides used on surfaces or patient instru-
ments and equipment), inactivate microorganisms. Disinfectants with
high-level effectiveness inactivate all microorganisms, with the
exception of high numbers of bacterial spores. Low-level disinfectants
kill most bacteria and some viruses and fungi, but they cannot be
relied on to kill more resistant microorganisms, such as tubercle
bacilli or bacterial spores.
The main objective of susceptibility testing of antibiotics is to pre-
dict the outcome of treatment with the antibiotics tested. The mini-
mum inhibitory concentration (MIC) is the fundamental measurement
that forms the basis for most susceptibility testing methods. The impli-
cation of the “susceptible” category implies that an infection due to the
strain being tested may be appropriately treated with the dosage of
antibiotic agent recommended for the type of infection and infecting
species. The breakpoint for determining susceptibility is based princi-
pally on pharmacokinetic parameters and results of in vitro studies,
animal studies, and human clinical trials. Many factors affect both the
validity of the test (eg, composition of the medium, size of the inocu-
lum, duration of incubation, temperature) and the actual clinical effi-
cacy of the therapy (eg, host defenses, site of infection, presence of a
foreign body or abscess).Table 2
Selected studies comparing germicide susceptibility in antibiotic resistant and susceptible str
Author (year) Bacteria studied Germicid
Al-Masaudi et al (1988)26 Staphylococcus aureus (MSSA, MRSA) Phenolics
Anderson et al (1997)27 Enterococcus (VSE, VRE) QAC, phe





Sakagami and Kajimura (2002)29 Enterococcus (VSE, VRE) Alcohol, c
formali




Wisplinghoff et al (2007)31 Acinetobacter baumannii Alcohol, c
Koo et al (2012)32 Klebsiella (NDM-1) Alcohol, c
Robustillo et al (2012)33 Klebsiella pneumoniae (KPC) Alcohol, c
chlorid
Campos et al (2012)34 MRSA Sodium h
QAC
KPC indicates Klebsiella pneumoniae carbapenemase; MRSA, methicillin-resistant Staphyloc
metallo-b-lactamase; QAC, quaternary ammonium compound; VRE, vancomycin-resistant EnResistant strains are not inhibited by the usual achievable sys-
temic concentrations of the agent with normal dosage schedules and/
or likely have specific microbial resistance mechanisms (eg, beta-lac-
tamases), and the clinical efficacy of agents to inhibit these strains
has not been reliably demonstrated in treatment studies. In contrast
to its precise use in reference to antibiotic therapy, the term “resis-
tant” has been used loosely when referring to the activity of a germi-
cide. Authors have described microbes that possess an elevated MIC
to a germicide as “resistant” even though the microbe is inactivated
by the germicide at its recommended use concentration. Thus, the
term “resistant” is incorrect when applied to pathogens exhibiting an
elevated MIC to a germicide. The more accurate terms are “reduced
susceptibility” or “increased tolerance.”
Most cases that are attributed by the user to resistance turn
out to be episodes in which the disinfectant was misused, includ-
ing (1) use of an inappropriate product (ie, the pathogen exhibits
intrinsic resistance to the disinfectant); (2) application of the
product without regard to proper duration, concentration, pH, or
temperature; (3) failure to remove organic debris (ie, improper
cleaning) prior to disinfection; (4) insufficient contact of the dis-
infectant with the surface to be treated; and (5) insufficient avail-
ability of the active product (eg, failure to use a proper dilution
of an iodophor, because free iodine may be present in lower con-
centrations in more concentrated products).MECHANISMS OF BACTERIAL RESISTANCE TO ANTIBIOTICS AND
GERMICIDES
As noted above, antibiotic resistance in several common human
pathogens is a worldwide problem. Antimicrobial resistance may be
intrinsic (an inherent property of the specific bacterial species) or
acquired. Mechanisms of intrinsic resistance include cell imperme-
ability and efflux.16,17 Common mechanisms of acquired resistance
include the following: target site alteration, altered cell permeability,
enzymatic modification or destruction, bypass of sensitive steps, or
efflux pumps.14,16,17 The mechanisms of germicide resistance are sim-
ilar to those responsible for antibiotic resistance, but there are some
differences (Table 1).ains
es evaluated Results
, chlorhexidine All strains were inactivated at the recommended
germicide concentrations.
nolic, iodophor All strains were inactivated at the recommended
germicide concentrations.
QAC In 20 comparative trials, only once did the antibi-








All strains were inactivated at the recommended
germicide concentrations.
hlorhexidine, iodine, triclosan All strains were inactivated at the recommended
germicide concentrations.




Routine disinfection was successful in curtailing
this outbreak.
ypochlorite, chlorhexidine, All strains were inactivated at the recommended
germicide concentrations.
occus aureus; MSSA, methicillin-susceptible Staphylococcus aureus; NDM-1, New Delhi
terococcus; VSE, vancomycin-susceptible Enterococcus.
Table 3
Summary of the relationship between germicide use and antibiotic resistance
Question Answer
Does the use of disinfectants or antiseptics result in disinfec-
tant and/or antiseptic resistance to the recommended con-
centrations of the antiseptics or disinfectants?
No
Do antibiotic-resistant bacteria exhibit resistance to the rec-
ommended concentrations of antiseptics or disinfectants?
No
Does the use of currently recommended hospital disinfectants
and/or antiseptics precipitate antibiotic resistance?
No
Does the recommended use of antiseptics and disinfectants in
hospitals decrease the burden of health care−associated
infections?
Yes
Conclusion: Regarding the continued use of antiseptics and disinfectants as cur-
rently recommended, the benefits overwhelming exceed the risks.LABORATORY-INDUCED REDUCED SUSCEPTIBILITY TO GERMICIDES
In the laboratory, it has been possible to develop mutants with
reduced susceptibility to germicides that demonstrate decreased
susceptibility or resistance to antibiotics. Reduced susceptibility
was most commonly shown to chlorhexidine, benzalkonium chlo-
ride, and triclosan. Importantly, the latter 2 agents are no longer
used in health care facilities.
INACTIVATION OF ANTIBIOTIC-RESISTANT BACTERIA BY
DISINFECTANTS
Multiple investigations of laboratory-induced cross-resistance
have frequently tested antibiotics that are of limited or no clinical
relevance (Table 1).26−34 Although some investigators described
reduced susceptibility to some germicides, resistance to recom-
mended use concentrations of the germicides was not reported.
Disinfectant classes tested included alcohols, aldehydes, iodine
compounds, cation surfactant and amphoteric compounds, and
biguanide-containing agents. Rarely, clinical or environmental
bacterial isolates, some associated with outbreaks, have demon-
strated survival at high or in-use concentrations of antiseptics or
low-level disinfectants.21 To date, widespread dissemination of a
bacterial strain resistant to the in-use concentration of commonly
used hospital antiseptics or disinfectants has not been reported.
In addition, the susceptibility of antibiotic-resistant pathogens to
surface disinfectants used at the appropriate dilution has been
investigated. When germicides were diluted to their recom-
mended use dilution (or even below), antibiotic-resistant patho-
gens did not demonstrate reduced susceptibility to germicides
(Table 2). Table 3 summarizes the relationship between germicide
use and antibiotic resistance.
RELEVANCE OF QAC GENES IN STAPHYLOCOCCI
Staphylococci are the only bacteria in which the genetic aspects of
plasmid-mediated antiseptic- and disinfectant-resistant mechanisms
have been described. Decreased susceptibility to chlorhexidine and
quaternary ammonium compounds has been reported to be wide-
spread among methicillin-resistant Staphylococcus aureus strains. Tol-
erance is mediated by the QAC family of genes, which code for
proton-dependent export proteins involved in an efflux system that
actively reduces intracellular accumulation of toxicants, such as qua-
ternary ammonium compounds. Strains carrying QAC genes may
exhibit reduced susceptibility to aminoglycosides and/or tetracycline.
Coagulase-negative staphylococci frequently also contain QAC genes.
Studies have established that the QAC genes consist of 2 gene families,
QACCD (now referred to as SMR) and QACAB.References
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